[EN] PATHWAY SPECIFIC ASSAYS FOR PREDICTING IRRITABLE BOWEL SYNDROME DIAGNOSIS [FR] DOSAGES SPÉCIFIQUES DES VOIES DE SIGNALISATION POUR LA PRÉDICTION DE DIAGNOSTIC DU SYNDROME DU CÔLON IRRITABLE
2-AMINOBENZOXAZOLE CARBOXAMIDES AS 5HT3 MODULATORS
申请人:Yang Zhicai
公开号:US20080255114A1
公开(公告)日:2008-10-16
Compounds of formulae I, II and III:
are disclosed as 5-HT3 inhibitors. The compounds are useful in treating CINV, IBS-D and other diseases and conditions.
2-aminobenzoxazole carboxamides as 5HT3 modulators
申请人:Albany Molecular Research, Inc.
公开号:US07863271B2
公开(公告)日:2011-01-04
Compounds of formulae I, II and III:
are disclosed as 5-HT3 inhibitors. The compounds are useful in treating CINV, IBS-D and other diseases and conditions.
PATHWAY SPECIFIC ASSAYS FOR PREDICTING IRRITABLE BOWEL SYNDROME DIAGNOSIS
申请人:NESTEC S.A.
公开号:US20160130279A1
公开(公告)日:2016-05-12
The present invention provides antibodies and methods for preparing antibodies to metabolites in the serotonin, tryptophan, kynurenine pathways. The prepared antibodies have low cross-reactivity to related metabolites, and are useful reagents for specific and sensitive immunoassays The present invention also provides stable derivatives of various metabolites and short chain fatty acids. The derivative can be conjugated to a biomolecule such as a carrier protein and combined with an adjuvant to stimulate an immune response. The derivatives can also be conjugated to other biomolecules.
[EN] 2-AMINOBENZOXAZOLE CARBOXAMIDES AS 5HT3 MODULATORS<br/>[FR] 2-AMINOBENZOXAZOLE CARBOXAMIDES EN TANT QUE MODULATEURS DE 5HT3
申请人:AMR TECHNOLOGY INC
公开号:WO2008019372A2
公开(公告)日:2008-02-14
[EN] Compounds of Formulae (I), (II) and (III): are disclosed as 5-HT3 inhibitors. The compounds are useful in treating CINV, IBS-D and other diseases and conditions. [FR] L'invention concerne des composés de formule I, II et III utilisés comme inhibiteurs de 5-HT3. Les composés sont utiles pour traiter des nausées et vomissements provoqués par la chimiothérapie (NVPC), un syndrôme du côlon irritable à prédominance de diarrhée (IBS-D) et d'autres maladies et conditions.